Author:
Vanlalpeka Harvey,Mawii Vanrem,Fela Lalrin,Chhungi Lalduh,Sailo Rothangpuii,Lalramhluna P. C.,Vanchhawng Pauline Lallianzuali,Zuali Lalfak,Lalrohlua P. C.,Ralte Lalengkimi,Dawngliana Malsawm,Kumar Nachimuthu Senthil
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Choi S, Ismail A, Pappas-Gogos G, Boussios S. HPV and cervical cancer: a review of epidemiology and screening uptake in the UK. Pathogens. 2023;12(2):298.
2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
3. Report of National Cancer Registry Programme (ICMR-NCDIR), Bengaluru, India 2020. https://www.ncdirindia.org/All_Reports/Report_2020/default.aspx. Accessed 15 May 2023
4. Manini I, Montomoli E. Epidemiology and prevention of Human Papillomavirus. Ann Ig. 2018;30:28–32.
5. Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017;8(8):CD008587.